Ameriprise
TMCI icon

Ameriprise’s Treace Medical Concepts TMCI Stock Holding History

Ameriprise’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,962
Closed -$313K – 3941
2024
Q1 		$313K Buy
23,962
+707
+3% +$9.43K ﹤0.01% 3571
2023
Q4 		$297K Sell
23,255
-82,179
-78% -$830K ﹤0.01% 3613
2023
Q3 		$1.38M Sell
105,434
-72,324
-41% -$1.32M ﹤0.01% 3003
2023
Q2 		$4.55M Buy
177,758
+39,154
+28% +$1.01M ﹤0.01% 2414
2023
Q1 		$3.49M Buy
138,604
+43,296
+45% +$1.02M ﹤0.01% 2556
2022
Q4 		$2.19M Buy
+95,308
New +$2.19M ﹤0.01% 2766

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise's TMCI Position: Q2 2024 in Review

Ameriprise sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 23,962 shares — an estimated $313K sold.

Ameriprise first reported a position in TMCI in Q4 2022 and held it in 6 quarters. The position peaked at $4.55M in Q2 2023. 127 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

  • Ameriprise reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
  • Ameriprise sold 23,962 Treace Medical Concepts shares in Q2 2024, an estimated $313K.
  • Ameriprise first reported a position in Treace Medical Concepts in Q4 2022 and held it in 6 quarters.
  • Ameriprise's Treace Medical Concepts position peaked at $4.55M in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on Ameriprise's 13F filing for Q2 2024, filed 14 Aug 2024.